The established model could serve as an independent prognostic biomarker, provide potential therapeutic targets for the clinical treatment of RCC, including ccRCC and pRCC, and add a dimension for correlation studies. This evidence concerns the gene PRCC and nonpapillary renal cell carcinoma.